Theratechnologies Inc TH.TO is expected to show a fall in quarterly revenue when it reports results on February 26 for the period ending November 30 2024
The Montreal Quebec-based company is expected to report a 3.2% decrease in revenue to $22.693 million from $23.45 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Theratechnologies Inc is for earnings of 5 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Theratechnologies Inc is $3.80, above its last closing price of $1.85.
This summary was machine generated February 24 at 13:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)